Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

NCT06156410 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma
Osteosarcoma
Sarcomas

Interventions

DRUG: Cabozantinib

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]
[object Object]
[object Object]